Skip to content

Case management after acquired brain injury

Case management after acquired brain injury

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26595
Enrollment
86
Registered
2019-10-22
Start date
2019-10-22
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired brain injury

Interventions

Case management The aim of case management for brain injury is to support patients’ and caregivers’ self-management of the consequences of brain injury and psychosocial well-being, to prevent (escalat
intensity of case management fluctuates over time, following patient and caregiver needs.

Sponsors

Maastricht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, patients must meet all of the following criteria: ? Acquired brain injury objectified by medical specialist ? Aged 18 years or older ? Living in the community prior to the injury ? Discharged home or to temporary care facility after hospital ? Sufficient command of the Dutch language ? Access to a computer and the internet ? Willing and able to give informed consent Primary caregivers (the informal caregiver who takes primary responsibility to care for the person with brain injury) of eligible patients are eligible when they are aged 18 years or older, have sufficient command of the Dutch language, have access to a computer and internet and are willing and able to give informed consent. Primary caregivers can only participate if the person with brain injury is participating. If the patient does not have a primary caregiver or if the caregiver is not willing to participate, this will not be an exclusion criterion for the patient.

Exclusion criteria

Exclusion criteria: A potential participant will be excluded from participation in this study when they have degenerative disorders (e.g. Parkinson’s disease, dementia) because of the progressive course of the disease. Patients with a diagnosis related to neuro-oncology will be excluded as well, since an intensive care trajectory is already in place for these patients.

Design outcomes

Primary

MeasureTime frame
The Hospital Anxiety and Depression Scale (HADS38) will be administered to assess symptoms of anxiety and depression. The scale consists of 14 items and two subscales (anxiety and depression). Scores >7 on a subscale suggest the presence of an anxiety disorder or depression. The psychometric quality of the scale is sufficient40.

Secondary

MeasureTime frame
Effectiveness will be evaluated by assessment of self-management (Patient Activation Measure (PAM)), psychosocial well-being (Utrecht Scale for Evaluation of Rehabilitation-Participation (USER-P) restriction subscale, the Life Satisfaction Questionnaire (LiSat) and the Hospital Anxiety and Depression Scale (HADS)), care needs (Longer-term Unmet Needs after Stroke (LUNS)). Caregiver outcomes include self-efficacy (Carer Self-Efficacy Scale (CSES)), caregiver burden (Caregiver Strain Index (CSI)), psychosocial well-being (LiSat, HADS), caregiver needs (Family Needs Questionnaire (FNQ)). Feasibility will be evaluated using qualitative methods, assessing fidelity, dose delivered, dose received, reach, recruitment and context. Cost-effectiveness will be determined by the EQ-5D-5L and service use (care consumption list).

Contacts

Public ContactChristine Resch

Maastricht University

christine.resch@maastrichtuniversity.nl0433881777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)